Cancer Research Meeting Calendar Telomeres
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gibson, S. L.
Right arrow Articles by Glazer, P. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gibson, S. L.
Right arrow Articles by Glazer, P. M.
[Cancer Research 65, 10734-10741, December 1, 2005]
© 2005 American Association for Cancer Research

Molecular Biology, Pathobiology and Genetics

Hypoxia-Induced Phosphorylation of Chk2 in an Ataxia Telangiectasia Mutated–Dependent Manner

Shannon L. Gibson1,3, Ranjit S. Bindra2,3 and Peter M. Glazer1,3

Departments of 1 Genetics, 2 Experimental Pathology, and 3 Therapeutic Radiology, Yale University School of Medicine, New Haven, Connecticut

Requests for reprints: Peter M. Glazer, Department of Therapeutic Radiology, Yale University School of Medicine, P.O. Box 208040, New Haven, CT 06520-0804. Phone: 203-737-2788; Fax: 203-785-6309; E-mail: peter.glazer{at}yale.edu

Chk2 is a serine/threonine kinase that signals to cell cycle arrest, DNA repair, and apoptotic pathways following DNA damage. It is activated by phosphorylation in response to ionizing radiation, UV light, stalled replication forks, and other types of DNA damage. Hypoxia is a common feature of solid tumors and has been shown to affect the regulation of many genes, including several DNA repair factors. We show here that Chk2 is phosphorylated on Thr68 and thereby activated in cells in response to hypoxia, and that this phosphorylation is dependent on the damage response kinase ataxia telangiectasia mutated (ATM) but not on the related kinase ATM and Rad3-related. Moreover, phosphorylation of Chk2 under hypoxia was attenuated in cells deficient in the repair factors MLH1 or NBS1. Finally, Chk2 serves to protect cells from apoptosis under hypoxic growth conditions. These results identify hypoxia as a new stimulus for Chk2 activation in an ATM-, MLH1-, and NBS1-dependent manner, and they suggest a novel pathway by which tumor hypoxia may influence cell survival and DNA repair.




This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
H. Muniyappa, S. Song, C. K. Mathews, and K. C. Das
Reactive Oxygen Species-independent Oxidation of Thioredoxin in Hypoxia: INACTIVATION OF RIBONUCLEOTIDE REDUCTASE AND REDOX-MEDIATED CHECKPOINT CONTROL
J. Biol. Chem., June 19, 2009; 284(25): 17069 - 17081.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. E. Crosby, R. Kulshreshtha, M. Ivan, and P. M. Glazer
MicroRNA Regulation of DNA Repair Gene Expression in Hypoxic Stress
Cancer Res., February 1, 2009; 69(3): 1221 - 1229.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
Z. Bencokova, M. R. Kaufmann, I. M. Pires, P. S. Lecane, A. J. Giaccia, and E. M. Hammond
ATM Activation and Signaling under Hypoxic Conditions
Mol. Cell. Biol., January 15, 2009; 29(2): 526 - 537.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
N. Chan, M. Koritzinsky, H. Zhao, R. Bindra, P. M. Glazer, S. Powell, A. Belmaaza, B. Wouters, and R. G. Bristow
Chronic Hypoxia Decreases Synthesis of Homologous Recombination Proteins to Offset Chemoresistance and Radioresistance
Cancer Res., January 15, 2008; 68(2): 605 - 614.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
H. Li, X. Ma, J. Wang, J. Koontz, M. Nucci, and J. Sklar
Effects of rearrangement and allelic exclusion of JJAZ1/SUZ12 on cell proliferation and survival
PNAS, December 11, 2007; 104(50): 20001 - 20006.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
P. G. Nuciforo, C. Luise, M. Capra, G. Pelosi, and F. d'Adda di Fagagna
Complex engagement of DNA damage response pathways in human cancer and in lung tumor progression
Carcinogenesis, October 1, 2007; 28(10): 2082 - 2088.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
C. Clavijo, J.-L. Chen, K.-J. Kim, M. E. Reyland, and D. K. Ann
Protein kinase C{delta}-dependent and -independent signaling in genotoxic response to treatment of desferroxamine, a hypoxia-mimetic agent
Am J Physiol Cell Physiol, June 1, 2007; 292(6): C2150 - C2160.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. C. Ghosh, T. Dohi, C. M. Raskett, T. F. Kowalik, and D. C. Altieri
Activated Checkpoint Kinase 2 Provides a Survival Signal for Tumor Cells
Cancer Res., December 15, 2006; 66(24): 11576 - 11579.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
R. A. Freiberg, E. M. Hammond, M. J. Dorie, S. M. Welford, and A. J. Giaccia
DNA Damage during Reoxygenation Elicits a Chk2-Dependent Checkpoint Response.
Mol. Cell. Biol., March 1, 2006; 26(5): 1598 - 1609.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2005 by the American Association for Cancer Research.